Solabia acquires Mibelle Biochemistry to boost beauty and wellness leadership
Key takeaways
- Solabia Group’s acquisition of Mibelle Biochemistry boosts its leadership in natural and bio-based active ingredients.
- The deal allows Persán to refocus on its core home and personal care markets while ensuring Mibelle Biochemistry’s growth under Solabia’s ownership.
- The acquisition opens the door to faster innovation and global expansion, with Solabia and Mibelle aiming to deliver cutting-edge, science-backed beauty solutions.
Mibelle Biochemistry is set to be sold to Solabia Group. Persán, a European player in home and personal care, has entered into an agreement to sell the ingredients supplier.
The transaction is expected to allow Persán to focus on its core business areas while ensuring that Mibelle Biochemistry continues to grow under a specialized owner in cosmetic and nutraceutical ingredients. It closely follows Persán’s acquisition of the Mibelle Group from Swiss retailer Migros last April.
Antonio Somé, CEO of Persán, says: “We’re pleased to have found in Solabia an excellent new owner for Mibelle Biochemistry whose expertise and long-term vision will support Mibelle Biochemistry’s growth in the future. For Persán, this step also enables us to… generate the greatest impact and long-term value, further growing our business globally.”
Financial details of the deal have not been disclosed, but the transaction is expected to close in the next few months.
Supporting long-term growth
The acquisition of Mibelle Biochemistry is expected to strengthen Solabia’s leadership in natural active ingredients by bringing together complementary technologies and product strengths, especially in natural and bio-based actives. Customers benefit from a broader portfolio while continuing to rely on Mibelle Biochemistry’s well-known Swiss-made quality.
“Mibelle Biochemistry is a company we have long admired for its scientific rigor, innovative spirit, and pioneering work,” says Jean Baptiste Dellon, CEO of Solabia. “Together, we will accelerate innovation, expand our global reach, and deliver even stronger value to a larger customer base seeking differentiated, science-backed solutions for beauty and well-being.”
Headquartered in Paris, the Solabia Group operates 11 manufacturing sites, eight R&D labs worldwide, and employs over 900 people.
Mibelle Group specializes in personal care, beauty, home care, nutrition, and developing active ingredients for the cosmetics and nutraceutical industries.Over 50 employees of the Mibelle Biochemistry division will continue to work under Solabia’s new ownership.
Moves by Mibelle
Mibelle Biochemistry continues to develop its reach in the beauty and wellness arena. In November, the company launched SenoCellTec, a plant-based active ingredient designed to eliminate “zombie cells” and rejuvenate skin. The ingredient aims to target the root cause of aging by working at the cellular level.
In a separate launch in June, Mibelle Biochemistry unveiled LunaRose, an organic ingredient for overnight skin care formulations. It acts on biological processes closely linked to sleep and supports skin regeneration. It is suitable for various formulations and works to reduce common signs of sleep deprivation, such as dark circles, dull skin, and sleep wrinkles.
According to Cornelia Schürch, head of Mibelle Biochemistry, the company has built “a global reputation for cutting-edge biotechnology and high-quality natural active ingredients over more than three decades.”
“We are gaining a strong, highly aligned partner who understands our markets and shares our passion for scientific excellence. This transaction will allow us to innovate faster, scale our technologies, and bring even more impactful ingredients to customers around the world,” says Schürch.
